Literature DB >> 6188914

Differential pharmacological properties of beta-adrenoceptor blocking drugs.

P A van Zwieten, P B Timmermans.   

Abstract

After a short introduction on the basic physiology of alpha- and beta-adrenoceptors, including their subdivisions into pre- and postsynaptic subtypes, the principle of competitive antagonism at the level of postjunctional beta-receptor subtypes is explained. Moreover, properties like membrane-stabilizing potency, beta 1-receptor selectivity (cardioselectivity), and intrinsic sympathomimetic activity are discussed at a molecular level. The most frequent applications of beta-adrenoceptor blocking agents in cardiovascular disease, neurology, psychiatry, ophthalmology, and endocrine disorders are enumerated and discussed at a pharmacological level, together with side effects, contraindications, and interactions with other drugs.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6188914     DOI: 10.1097/00005344-198300051-00001

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  3 in total

Review 1.  Exercise metabolism and beta-blocker therapy. An update.

Authors:  A Head
Journal:  Sports Med       Date:  1999-02       Impact factor: 11.136

Review 2.  Effects of antihypertensive drugs on the unborn child: what is known, and how should this influence prescribing?

Authors:  S M Khedun; B Maharaj; J Moodley
Journal:  Paediatr Drugs       Date:  2000 Nov-Dec       Impact factor: 3.022

3.  Beta-Blocker-Related Atrioventricular Conduction Disorders-A Single Tertiary Referral Center Experience.

Authors:  Dragoș Traian Marius Marcu; Cristina Andreea Adam; Dan-Mihai Dorobanțu; Delia Lidia Șalaru; Radu Andy Sascău; Mircea Ovanez Balasanian; Liviu Macovei; Cătălina Arsenescu-Georgescu; Cristian Stătescu
Journal:  Medicina (Kaunas)       Date:  2022-02-20       Impact factor: 2.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.